logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
B

Bristol-Myers Squibb

Scholars1.2W
Papers5.7K
Citations18
Related Papers (2604)
Publication Date
delete
A global model for symptomatic obstructive hypertrophic cardiomyopathy to assess the cost-effectiveness of mavacamten: results from a Dutch societal perspective
errJournal of Medical Economics
IF3
err2026-06-08
err0
errOAAI
errVarun Ektare; Claire Simons; Kasper Johannesen; Taryn Krause; Carla L. Zema; Leander R. Buisman; Maarten Treur; Ana Moura; Manikanta Dasari; Melissa Verkaik; Gijs van de Wetering; Linde Pronk; Marjolein Pompen; Xiaoyan Li; Marta Contente; Christian Knackstedt; Michael Hurst
errShare
errSave
Subcutaneous drug delivery of high concentration antibody products – part 2: formulation, device options, and clinical bridging strategies for patient-centric commercial presentations
errmAbs
IF7.3
err2026-06-08
err0
errOAAI
errIndrajit Ghosh; Suyash Deodhar; Hiten Gutka; Srini Sridharan; Dilbir Bindra
errShare
errSave
Longitudinal cognitive assessment using the Cumulus NeuLogiq platform in amyotrophic lateral sclerosis and frontotemporal dementia
errScientific Reports
IF3.9
err2026-06-01
err0
errOAAI
errEmmet Costello; Kimberly Kiyui; Ciara Brennan; Niamh Ni Obain; Sophie Leonard; Mark Heverin; Florentine Barbey; John Dyer; Laura Rueda-Delgado; Shannon Diggin; Elizabeth Tunbridge; Hugh Marston; Robert Y.K. Lai; Richard Hargreaves; Leslie Shinobu; Viet Nguyen; Ann Marie Hake; Gerard Dawson; Robert Latzman; Alison Buick; Brian Murphy; Orla Hardiman; Niall Pender
errShare
errSave
Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing–Remitting Multiple Sclerosis
errInternational Journal of Molecular Sciences
IF4.9
err2026-05-29
err0
errOAAI
errLucienne Costa-Frossard; Luis Brieva; Daniel Apolinar García-Estévez; Jesús Manuel Martín-Martínez; Gary Álvarez-Bravo; María Rosario Blasco-Quílez; José E. Meca-Lallana; María Carmen Calles-Hernández; Cristina Ramo Tello; Carmen Muñoz-Fernández; David Enrique Barbero; Pablo López-Muñoz; José María Prieto González; Antonio Candeliere-Merlicco; Olga Carmona; Javier Riancho; Nuria Sola-Valls; María Carcelén-Gadea; Laura Borrega; Francisco Gascón-Giménez; David Vilanova; Xavier Pérez; Luisa María Villar
errShare
errSave
Protein Homeostasis Screen Identifies CK2 Inhibition as a Driver of CARD9 Depletion
errACS Chemical Biology
IF3.8
err2026-05-16
err0
PREAI
errAya M. Kelly; Leidy C. Merselis; Benjamin Causton; Olivia K. Calder; Hoson Chao; Margaret Prack; Laurel B. Stine; Yuka Amako; Tao Wang; Ali E. Yesilkanal; Kendall J. Condon; Meekyum O. Pierce; Scott H. Watterson; Jason Guernon; Amit Anand; Sabariya Selvam; Sayali Dagde; Emily Holzinger; Lauren Piasecki; Travis A. Pemberton; Emily Fu; McKenna Joint; Hayden Sandt; Ashish K. Singh; Tai Wang; Denise Cobb; Xiaochun Ni; Geraint H. M. Davies; Alan F. Corin; Sophie Roy; Stephen C. Wilson
errShare
errSave
Molecular Behavior of Antibodies IgG-1 and IgG-4 at Buried Polymer/Solution Interfaces Probed by Sum Frequency Generation Vibrational Spectroscopy
errAnalytical Chemistry
IF6.7
err2026-05-07
err0
PREAI
errXuhong Chen; Zahra Asif Gandhi; Guangyao Wu; Edward Hu; Ankit D. Kanthe; Duohai Pan; Zhan Chen
errShare
errSave
Discovery of BMS-159; an Orally Active Imidazotriazine Pan-CK2 Inhibitor for the Treatment of Cancer
errACS Medicinal Chemistry Letters
IF4
err2026-04-22
err0
PREAI
errChristine M. Tarby; Amy Hart; Honghe Wan; Liqi He; John Tokarski; Brian Fink; Yufen Zhao; Tram Huynh; Ashvinikumar Gavai; Kurt Zimmermann; Gregory Vite; Dolatrai Vyas; Jennifer Inghrim; Mary Obermeier; Aberra Fura; Paul Elzinga; John Hunt; Urvashi Roongta; Benjamin Henley; Jonathan Lippy; Arvind Mathur; Dauh Rurng Wu; Peng Li; Nirmala Raghavan; Gerry Everlof; Brent Rupnow; Francis Lee; Joseph Fargnoli; Jeffrey Tredup; Susan E. Kiefer; Deepa Calambur; Anuradha Gupta; Muthalagu Vetrichelvan; Murugaiah A. M. Subbaiah; Ashok V. Purandare
errShare
errSave
Naturally self-reactive B cells are poised to cross the selection barrier into autoimmune germinal centers
errCell Reports
IF6.9
err2026-04-08
err0
errOAAI
errDanni Yi-Dan Zhu; Maya Sangesland; Vintus Okonkwo; Zhenrui Zhang; Victoria Rosado; Larance Ronsard; Caitlin McCarthy; Caroline Alexander; Ralston M. Barnes; Daniel Rohrer; Nils Lonberg; Debashree Tagore; Musie Ghebremichael; Carlos Castrillon; Joshua M. Akey; Michael C. Carroll; Daniel Lingwood
errShare
errSave
Discovery of Novel 2-Morpholine Tetrahydroisoquinoline CXCR4 Antagonists with Unique Properties
errJournal of Medicinal Chemistry
IF6.8
err2026-04-06
err0
errOAAI
errYesim Altas Tahirovic; Zafer Sahin; Edgars Jecs; Eric J. Miller; Huy H. Nguyen; Robert J. Wilson; Michelle Kim; Marshall Fritz; Yusr Zaghlula; Savita K. Sharma; Perry Bartsch; Tao Wang; Chi S. Sum; Mary E. Cvijic; Anthony A. Paiva; Gretchen M. Schroeder; Lawrence J. Wilson; Dennis C. Liotta
errShare
errSave
An efficient and robust strategy for developing cell lines through targeted integration
errBiotechnology Progress
IF2.5
err2026-04-01
err0
PREAI
errMcVey, Duncan; Garg, Charu; Wang, Chaojie; Awan, Aashir; Zheng, Rui; Zhang, Jennifer; Sturner, Steve; Langsdorf, Erik; Yu, Le; Shankarling, Krishnamurthy; Rizzi, Giovanni; Agarwal, Kitty; Tremml, Gabi; Khetan, Anurag
errShare
errSave
Design and rationale for a phase 3 trial of admilparant (BMS-986278), an oral lysophosphatidic acid receptor 1 antagonist, in patients with idiopathic pulmonary fibrosis: ALOFT-IPF
errPneumologie
IF1.7
err2026-03-01
err0
PREAI
errMaher, T.; Wijsenbeek, M. S.; Kreuter, M.; Fischer, A.; Kim, S.; Patel, A.; Elsharkawi, W.
errShare
errSave
First Method for Trace-Level Quantification of the Potential Genotoxic Impurity Bis(neopentyl glycolato)diboron Using GC-MS
errORGANIC PROCESS RESEARCH & DEVELOPMENT
IF3.5
err2026-03-01
err0
PREAI
errKushwah, Bhoopendra Singh; Kadambar, Vasantha Krishna; Peddicord, Michael B.; Marshall, Jonathan; Rajendran, Ashok Kumar; Tamboli, Vajir Fakirsab; Natarajan, Saravanan; Bajpai, Lakshmikant; Young, Joel
errShare
errSave
Exome sequencing and analysis of 44,028 British South Asians enriched for high autozygosity
errNature Genetics
IF29
err2026-03-01
err0
PREAI
errKim, Hye In; Deboever, Christopher; Walter, Klaudia; Kalantzis, Georgios; Li, Chen; Mozaffari, Sahar V.; Kundu, Kousik; Jacobs, Benjamin M.; Mohammadi-Shemirani, Pedrum; Musolf, Anthony M.; Davitte, Jonathan M.; Aksit, Melis A.; Gafton, Joseph; Catalano, Katrina A.; Dawed, Adem Y.; Graham, Robert R.; Guo, Bin; Gupta, Namrata; Heng, Teng Hiang; Hunt, Karen A.; Iyer, Vivek; Langenberg, Claudia; Lassen, Frederik H.; MacArthur, Daniel G.; Maher, Eamonn R.; Maroteau, Cyrielle; Newman, William G.; O'rahilly, Stephen; Palmer, Duncan S.; Popov, Iaroslav; Siddiqui, Moneeza K.; Simpson, Michael A.; Spreckley, Marie; Wright, John; Del Angel, Guillermo; Petrovski, Slave; Holzinger, Emily R.; Maranville, Joseph C.; Addis, Laura; Turner, Richard M.; Estrada, Karol; Longerich, Simone; Howson, Joanna M. M.; Jamshidi, Yalda; Fauman, Eric B.; Miller, Melissa R.; Diogo, Dorothee; Trembath, Richard C.; Finer, Sarah; Martin, Hilary C.; van Heel, David A.
errShare
errSave
Advancing cell and gene therapy: Application of AI/ML in clinical development and patient management
errJournal of Biopharmaceutical Statistics
IF1.2
err2026-03-01
err0
PREAI
errSpeth, Kelly; Sengupta, Sanhita; Shamsuzzaman, Md; Whitmore, James; Li, Daniel; Chiang, Alan Y.; Xu, Zhenzhen; Song, Qinghua
errShare
errSave
Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sclerosis
errInflammatory Bowel Diseases
IF4.3
err2026-02-01
err0
PREAI
errRubin, David T.; Danese, Silvio; Nakase, Hiroshi; Ungaro, Ryan C.; Wolf, Douglas C.; Alekseeva, Olga; Petersen, AnnKatrin; Liu, Zhaohui; Mehra, Dimpy; Jain, Anjali; Osterman, Mark T.; Krakovich, Anthony; Riolo, Jon, V; DeBoer, Erik; Appio, James; Sinh, Preetika; Cree, Bruce A. C.; Cohen, Jeffrey A.; Irving, Peter
errShare
errSave
FIH Dose Selection Beyond MABEL: Optimizing Phase 1 clinical trial Starting Dose Whilst Protecting Patient Safety
errRegulatory Toxicology and Pharmacology
IF3.5
err2026-01-30
err0
PREAI
errMineo Matsumoto; J.Ryan Polli; Suresh Swaminathan; Kaushik Datta; Cris Kamperschroer; Marie C. Fortin; Smita Salian-Mehta; Rutwij Dave; Zheng Yang; Payal Arora; Masanori Hiura; Mizuho Suzuki; Christine E. Crute; Frank R. Brennan; Jean Sathish
errShare
errSave
Latent Variable Indirect Response Modeling of Cendakimab Exposure–Response for Longitudinal Dysphagia Days Using a Combined Uniform-Binomial Likelihood Framework
errcpt: pharmacometrics & systems pharmacology
IF0
err2026-01-23
err0
errOAAI
errShengnan Du; Jessica Wojciechowski; Peijin Zhang; Urvi Aras; Bindu Murthy; Jun Shen; Anna Kondic; Chuanpu Hu
errShare
errSave
SLE-diseaseome: a comprehensive meta-collection of systemic lupus erythematosus relevant functional pathways
errBioinformatics Advances
IF2.8
err2026-01-01
err0
PREAI
errToro-Dominguez, Daniel; Wang, Chang; Ellson-Lancho, Ivan; Martorell-Marugan, Jordi; Carmona-Saez, Pedro; Alarcon-Riquelme, Marta E.; Baribaud, Frederic
errShare
errSave
How to discriminate between ASMR V drugs: what are the implications and what is the access pathway?
errTherapie
IF1.8
err2026-01-01
err0
errOAAI
errBody, Clementine; Chassagnol, Frederic; Berdai, Driss; Bergmann, Jean-Francois; Borget, Isabelle; Dore, Carole; Durr, Alexandra; Falissard, Bruno; Hudry, Joumana; Kowalski, Benjamin; Maugendre, Philippe; Schlumberger, Nicolas; Wilmet, Elodie; Le Jeunne, Claire
errShare
errSave
Quantile Effect on Duration of Response: A Zero-Inflated Censored Regression Approach
errPharmaceutical Statistics
IF1.4
err2025-11-01
err0
PREAI
errSun, Nan; Wang, Jixian; Tiwari, Ram
errShare
errSave